Amgen at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Amgen brings 4 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 501, Suite 22, Suite 23. Its program spans the treatment journey with GLP-1 drugs, including medical costs by whether patients stay on therapy, and mouse studies comparing blocking and activating the GIP receptor. It also tests how well BMI matches central fat and body composition in UK Biobank.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Amgen Thousand Oaks, CA | ◆Silver Sponsor |
Biotechnology company drawing on biology, technology and human genetic data to develop medicines for serious diseases. | Booth Exhibiting at Booth 501, Suite 22, Suite 23 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Poster Sat Nov 14 7:30pm–8:30pm Brain Activation Profiling and Tissue-Based Omics in Mice Exposed to GIPR Antagonism Versus Agonism Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology Talk Sun Nov 15 7:30am–8:30am The Obesity Treatment Journey: Evaluating Burden, Discontinuation, and Outcomes Uses a patient case and real-world data to examine why patients stop obesity treatment, what follows, and care changes that keep people on therapy. Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodChronic disease and obesity complicationsNeuroscience of appetite and eatingObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm Medical Cost and Use by GLP-1 RA Persistence Status in US Patients With Obesity/Overweight Clinical obesity care and professional practice Poster Mon Nov 16 2:30pm–3:30pm Correlation of BMI With Central Adiposity and Body Composition Measures in UK Biobank Population health and epidemiology |
Find decision makers at Amgen
Tell us what you sell and we’ll find the people at Amgen most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction